16:18 EST Lipocine files $150M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LPCN:
- Lipocine releases late breaking presentation on LPCN 1148 Phase 2 results
- Lipocine price target lowered to $33 from $36 at Ladenburg
- Lipocine reports Q3 EPS ($1.27), consensus (60c)
- Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
- LPCN Earnings Report this Week: Is It a Buy, Ahead of Earnings?